Yicheng Qi and Xiaoli Li contributed equally to this work.
The role of osteopontin in the induction of the CD40 ligand in Graves' disease
Article first published online: 3 JUN 2013
© 2013 John Wiley & Sons Ltd.
Volume 80, Issue 1, pages 128–134, January 2014
How to Cite
Qi, Y., Li, X., Ma, X., Xu, L., Zhang, X., Jiang, X., Hong, J., Cui, B., Ning, G. and Wang, S. (2014), The role of osteopontin in the induction of the CD40 ligand in Graves' disease. Clinical Endocrinology, 80: 128–134. doi: 10.1111/cen.12229
- Issue published online: 5 DEC 2013
- Article first published online: 3 JUN 2013
- Accepted manuscript online: 26 APR 2013 04:39AM EST
- Manuscript Accepted: 22 APR 2013
- Manuscript Revised: 16 APR 2013
- Manuscript Revised: 22 FEB 2013
- Manuscript Received: 22 JAN 2013
- National Natural Science Foundation of China. Grant Number: 81270872
- Shanghai Municipal Natural Science Foundation. Grant Number: 11495803400
- Ministry of Health. Grant Numbers: 201002002, 201202008
- National Key New Drug Creation
- Manufacturing Program of Ministry of Science and Technology. Grant Number: 2012ZX09303006-001
Fig S1. Correlation between the level of CD40L on CD4+ T cells and sCD40L level.
Fig S2. Plasma OPN level in normal controls, initial GD patients, and GD patients in remission.
Table S1. The correlation of OPN level with classic GD diagnostic parameters.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.